Genexine, Inc. (KOSDAQ:095700)

South Korea · Delayed Price · Currency is KRW

4,370.00

-65.00 (-1.47%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008
Biotechnology	4.43B	16.14B	36.83B	18.54B	11.30B
Biotechnology Growth	-72.57%	-56.18%	98.61%	64.06%	80.80%
Total	4.43B	16.14B	36.83B	18.54B	11.30B
Total Growth	-72.57%	-56.18%	98.61%	64.06%	80.80%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008
South Korea	1.72B	1.70B	2.90B	9.87B	11.30B
South Korea Growth	1.43%	-41.34%	-70.65%	-12.64%	101.16%
Asia	25.01M	9.95B	29.92B	689.79M	-
Asia Growth	-99.75%	-66.73%	4237.17%	-	-
Americas	2.68B	4.49B	4.01B	7.98B	-
Americas Growth	-40.31%	11.77%	-49.70%	-	-
Total	4.43B	16.14B	36.83B	18.54B	11.30B
Total Growth	-72.57%	-56.18%	98.61%	64.06%	80.80%

Source: S&P Global Market Intelligence.